Ozempic was found in a 2025 clinical trial to reduce measurable biological age in adults by approximately 3 to 5 years — with improvements in inflammation, cardiovascular health, and kidney function
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Ozempic was found in a 2025 clinical trial to reduce measurable biological age in adults by approximately 3 to 5 years — with improvements in inflammation, cardiovascular health, and kidney function" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Medical News Today, Conexiant, Yahoo and University of California. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 154d ago.
Quick answers
Why is "Ozempic was found in a 2025 clinical trial to reduce measurable biological age i" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Semaglutide, omega-3s and diet shift epigenetic aging clocks in human studies News-Medical · 155d ago
- UC San Diego researchers explore whether a GLP-1 drug can slow biological aging KPBS · 155d ago
- Semaglutide and aging: New study finds benefits beyond weight loss Medical News Today · 155d ago
- Semaglutide Tied to Aging Clocks in HIV Conexiant · 155d ago
- Weight loss drugs show signs of slowing biological aging, scientists discover Yahoo · 155d ago
- New study shows popular GLP-1 weight loss drug may slow biological aging University of California · 155d ago
- Ozempic was found in a 2025 clinical trial to reduce measurable biological age in adults by approximately 3 to 5 years — with improvements in inflammation, cardiovascular health, and kidney function Space Daily · 155d ago
Topics
Related trends
Ozempic and Mounjaro may have a surprising effect on your brain
Coverage from five outlets reports that Ozempic and Mounjaro may affect memory and brain function, with evidence described as mixed.
Should you take GLP-1s during pregnancy? What some doctors say.
New research on GLP-1 drugs during pregnancy sparks urgent debate among doctors and patients.
The GLP-1 boom has a dark side
FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Internal medicine physician Dr. Frank Dumont warns that stopping GLP-1 medications like Ozempic and Zepbound carries six rebound risks, including rapid weight regain, loss of cardiovascular protection, and worsening mental health.
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
Federal regulators mandate new vision loss warning labels across the widely used GLP-1 receptor agonist drug class.
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
Federal regulators issue a new warning regarding GLP-1 medications and a rare eye condition linked to sudden blindness.